allo-HSCT	allogeneic hematopoietic stem cell transplantation
AML	acute myeloid leukemia
GVL	graft-versus-leukemia
NK	Natural killer
MRD	minimal residual disease
DLI	Donor lymphocyte infusion
ICIs	immune checkpoint inhibitors
HLA	human leukocyte antigen
TIGIT	T-cell immunoreceptor with Ig and immunoreceptor tyrosine-based inhibition motif domains
GVHD	graft versus host disease
OS	overall survival
Tregs	T-regulatory cells
CR	complete remission
KIRs	killer immunoglobulin-like receptors
PD-1	programmed cell death protein 1
CTLA-4	cytotoxic T-lymphocyte-associated protein 4
TIM-3	T-cell immunoglobulin and mucin domain-containing protein 3
LAG-3	lymphocyte activation gene 3
BTLA	B- and T-lymphocyte attenuator
MDSC	myeloid-derived suppressor cell
HVEM	herpesvirus entry mediator
BiKEs	bispecific killer cell engagers
TriKEs	trispecific killer cell engagers
MDS	myelodysplastic syndromes
CARs	chimeric antigen receptors
HSCs	hematopoietic stem cells
MICA	MHC class I-related chain A
ULBP1	UL16-binding protein 1
HSC_BM	hematopoietic stem cells from bone marrow
early HPC_BM	hematopoietic progenitor cells from bone marrow
CMP	common myeloid progenitor cell
GMP	granulocyte monocyte progenitors
MEP	megakaryocyte-erythroid progenitor cell
PM_BM	promyelocyte from bone marrow
MY_BM	myelocyte from bone marrow
PMN_BM	polymorphonuclear cells from bone marrow
PMN_PB	polymorphonuclear cells from peripheral blood
B-cells	CD19+ B-cells
NK cells	CD56+ natural killer cells
mDC	CD11c+ myeloid dendritic cells
pDC	CD123+ plasmacytoid dendritic cells
HMs	hematological malignancies
ML	malignant lymphoma
ALL	acute lymphoblastic leukemia
JAK	Janus kinase
IFN	interferon